Global Biosimilar Industry Research Report 2023 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027

Report ID: 582488 | Published Date: Jan 2025 | No. of Page: 162 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview

1.1 Study Scope and Definition

1.2 Research Methodology

1.2.1 Methodology/Research Approach

1.2.2 Data Source

1.3 Key Market Segments

1.4 Players Covered: Ranking by Biosimilar Revenue

1.5 Market Analysis by Type

1.5.1 Global Biosimilar Market Size Growth Rate by Type: 2021 VS 2027

1.5.2 Human Growth Hormones

1.5.3 Monoclonal Antibodies

1.5.4 Insulin

1.5.5 Peptides

1.5.6 Erythropoietin

1.5.7 Others

1.6 Market by Application

1.6.1 Global Biosimilar Market Share by Application: 2022-2027

1.6.2 Oncology

1.6.3 Chronic and Autoimmune Diseases

1.6.4 Growth Hormone Deficiency

1.6.5 Infectious Diseases

1.6.6 Others

1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections

1.7.2 Covid-19 Impact: Commodity Prices Indices

1.7.3 Covid-19 Impact: Global Major Government Policy

1.8 Study Objectives

1.9 Years Considered

2 Global Biosimilar Market Trends and Growth Strategy

2.1 Market Top Trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Porter’s Five Forces Analysis

2.5 Market Growth Strategy

2.6 SWOT Analysis

3 Global Biosimilar Market Players Profiles

3.1 Allergan plc

3.1.1 Allergan plc Company Profile

3.1.2 Allergan plc Biosimilar Product Specification

3.1.3 Allergan plc Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.2 BIOCAD

3.2.1 BIOCAD Company Profile

3.2.2 BIOCAD Biosimilar Product Specification

3.2.3 BIOCAD Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.3 Biocon

3.3.1 Biocon Company Profile

3.3.2 Biocon Biosimilar Product Specification

3.3.3 Biocon Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 BioXpress Therapeutics

3.4.1 BioXpress Therapeutics Company Profile

3.4.2 BioXpress Therapeutics Biosimilar Product Specification

3.4.3 BioXpress Therapeutics Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 Boehringer Ingelheim

3.5.1 Boehringer Ingelheim Company Profile

3.5.2 Boehringer Ingelheim Biosimilar Product Specification

3.5.3 Boehringer Ingelheim Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 Celltrion

3.6.1 Celltrion Company Profile

3.6.2 Celltrion Biosimilar Product Specification

3.6.3 Celltrion Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 Coherus BioSciences

3.7.1 Coherus BioSciences Company Profile

3.7.2 Coherus BioSciences Biosimilar Product Specification

3.7.3 Coherus BioSciences Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 Dr. Reddy’s Laboratories

3.8.1 Dr. Reddy’s Laboratories Company Profile

3.8.2 Dr. Reddy’s Laboratories Biosimilar Product Specification

3.8.3 Dr. Reddy’s Laboratories Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.9 Genor BioPharma

3.9.1 Genor BioPharma Company Profile

3.9.2 Genor BioPharma Biosimilar Product Specification

3.9.3 Genor BioPharma Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.10 Intas Pharmaceuticals Limited

3.10.1 Intas Pharmaceuticals Limited Company Profile

3.10.2 Intas Pharmaceuticals Limited Biosimilar Product Specification

3.10.3 Intas Pharmaceuticals Limited Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.11 Novartis

3.11.1 Novartis Company Profile

3.11.2 Novartis Biosimilar Product Specification

3.11.3 Novartis Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.12 Pfizer

3.12.1 Pfizer Company Profile

3.12.2 Pfizer Biosimilar Product Specification

3.12.3 Pfizer Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.13 Reliance Life Sciences

3.13.1 Reliance Life Sciences Company Profile

3.13.2 Reliance Life Sciences Biosimilar Product Specification

3.13.3 Reliance Life Sciences Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Biosimilar Market Competition by Market Players

4.1 Global Biosimilar Production Capacity Market Share by Market Players (2016-2021)

4.2 Global Biosimilar Revenue Market Share by Market Players (2016-2021)

4.3 Global Biosimilar Average Price by Market Players (2016-2021)

5 Global Biosimilar Production by Regions (2016-2021)

5.1 North America

5.1.1 North America Biosimilar Market Size (2016-2021)

5.1.2 Biosimilar Key Players in North America (2016-2021)

5.1.3 North America Biosimilar Market Size by Type (2016-2021)

5.1.4 North America Biosimilar Market Size by Application (2016-2021)

5.2 East Asia

5.2.1 East Asia Biosimilar Market Size (2016-2021)

5.2.2 Biosimilar Key Players in East Asia (2016-2021)

5.2.3 East Asia Biosimilar Market Size by Type (2016-2021)

5.2.4 East Asia Biosimilar Market Size by Application (2016-2021)

5.3 Europe

5.3.1 Europe Biosimilar Market Size (2016-2021)

5.3.2 Biosimilar Key Players in Europe (2016-2021)

5.3.3 Europe Biosimilar Market Size by Type (2016-2021)

5.3.4 Europe Biosimilar Market Size by Application (2016-2021)

5.4 South Asia

5.4.1 South Asia Biosimilar Market Size (2016-2021)

5.4.2 Biosimilar Key Players in South Asia (2016-2021)

5.4.3 South Asia Biosimilar Market Size by Type (2016-2021)

5.4.4 South Asia Biosimilar Market Size by Application (2016-2021)

5.5 Southeast Asia

5.5.1 Southeast Asia Biosimilar Market Size (2016-2021)

5.5.2 Biosimilar Key Players in Southeast Asia (2016-2021)

5.5.3 Southeast Asia Biosimilar Market Size by Type (2016-2021)

5.5.4 Southeast Asia Biosimilar Market Size by Application (2016-2021)

5.6 Middle East

5.6.1 Middle East Biosimilar Market Size (2016-2021)

5.6.2 Biosimilar Key Players in Middle East (2016-2021)

5.6.3 Middle East Biosimilar Market Size by Type (2016-2021)

5.6.4 Middle East Biosimilar Market Size by Application (2016-2021)

5.7 Africa

5.7.1 Africa Biosimilar Market Size (2016-2021)

5.7.2 Biosimilar Key Players in Africa (2016-2021)

5.7.3 Africa Biosimilar Market Size by Type (2016-2021)

5.7.4 Africa Biosimilar Market Size by Application (2016-2021)

5.8 Oceania

5.8.1 Oceania Biosimilar Market Size (2016-2021)

5.8.2 Biosimilar Key Players in Oceania (2016-2021)

5.8.3 Oceania Biosimilar Market Size by Type (2016-2021)

5.8.4 Oceania Biosimilar Market Size by Application (2016-2021)

5.9 South America

5.9.1 South America Biosimilar Market Size (2016-2021)

5.9.2 Biosimilar Key Players in South America (2016-2021)

5.9.3 South America Biosimilar Market Size by Type (2016-2021)

5.9.4 South America Biosimilar Market Size by Application (2016-2021)

5.10 Rest of the World

5.10.1 Rest of the World Biosimilar Market Size (2016-2021)

5.10.2 Biosimilar Key Players in Rest of the World (2016-2021)

5.10.3 Rest of the World Biosimilar Market Size by Type (2016-2021)

5.10.4 Rest of the World Biosimilar Market Size by Application (2016-2021)

6 Global Biosimilar Consumption by Region (2016-2021)

6.1 North America

6.1.1 North America Biosimilar Consumption by Countries

6.1.2 United States

6.1.3 Canada

6.1.4 Mexico

6.2 East Asia

6.2.1 East Asia Biosimilar Consumption by Countries

6.2.2 China

6.2.3 Japan

6.2.4 South Korea

6.3 Europe

6.3.1 Europe Biosimilar Consumption by Countries

6.3.2 Germany

6.3.3 United Kingdom

6.3.4 France

6.3.5 Italy

6.3.6 Russia

6.3.7 Spain

6.3.8 Netherlands

6.3.9 Switzerland

6.3.10 Poland

6.4 South Asia

6.4.1 South Asia Biosimilar Consumption by Countries

6.4.2 India

6.5 Southeast Asia

6.5.1 Southeast Asia Biosimilar Consumption by Countries

6.5.2 Indonesia

6.5.3 Thailand

6.5.4 Singapore

6.5.5 Malaysia

6.5.6 Philippines

6.6 Middle East

6.6.1 Middle East Biosimilar Consumption by Countries

6.6.2 Turkey

6.6.3 Saudi Arabia

6.6.4 Iran

6.6.5 United Arab Emirates

6.7 Africa

6.7.1 Africa Biosimilar Consumption by Countries

6.7.2 Nigeria

6.7.3 South Africa

6.8 Oceania

6.8.1 Oceania Biosimilar Consumption by Countries

6.8.2 Australia

6.9 South America

6.9.1 South America Biosimilar Consumption by Countries

6.9.2 Brazil

6.9.3 Argentina

6.10 Rest of the World

6.10.1 Rest of the World Biosimilar Consumption by Countries

7 Global Biosimilar Production Forecast by Regions (2022-2027)

7.1 Global Forecasted Production of Biosimilar (2022-2027)

7.2 Global Forecasted Revenue of Biosimilar (2022-2027)

7.3 Global Forecasted Price of Biosimilar (2022-2027)

7.4 Global Forecasted Production of Biosimilar by Region (2022-2027)

7.4.1 North America Biosimilar Production, Revenue Forecast (2022-2027)

7.4.2 East Asia Biosimilar Production, Revenue Forecast (2022-2027)

7.4.3 Europe Biosimilar Production, Revenue Forecast (2022-2027)

7.4.4 South Asia Biosimilar Production, Revenue Forecast (2022-2027)

7.4.5 Southeast Asia Biosimilar Production, Revenue Forecast (2022-2027)

7.4.6 Middle East Biosimilar Production, Revenue Forecast (2022-2027)

7.4.7 Africa Biosimilar Production, Revenue Forecast (2022-2027)

7.4.8 Oceania Biosimilar Production, Revenue Forecast (2022-2027)

7.4.9 South America Biosimilar Production, Revenue Forecast (2022-2027)

7.4.10 Rest of the World Biosimilar Production, Revenue Forecast (2022-2027)

7.5 Forecast by Type and by Application (2022-2027)

7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

7.5.2 Global Forecasted Consumption of Biosimilar by Application (2022-2027)

8 Global Biosimilar Consumption Forecast by Regions (2022-2027)

8.1 North America Forecasted Consumption of Biosimilar by Country

8.2 East Asia Market Forecasted Consumption of Biosimilar by Country

8.3 Europe Market Forecasted Consumption of Biosimilar by Countriy

8.4 South Asia Forecasted Consumption of Biosimilar by Country

8.5 Southeast Asia Forecasted Consumption of Biosimilar by Country

8.6 Middle East Forecasted Consumption of Biosimilar by Country

8.7 Africa Forecasted Consumption of Biosimilar by Country

8.8 Oceania Forecasted Consumption of Biosimilar by Country

8.9 South America Forecasted Consumption of Biosimilar by Country

8.10 Rest of the world Forecasted Consumption of Biosimilar by Country

9 Global Biosimilar Sales by Type (2016-2027)

9.1 Global Biosimilar Historic Market Size by Type (2016-2021)

9.2 Global Biosimilar Forecasted Market Size by Type (2022-2027)

10 Global Biosimilar Consumption by Application (2016-2027)

10.1 Global Biosimilar Historic Market Size by Application (2016-2021)

10.2 Global Biosimilar Forecasted Market Size by Application (2022-2027)

11 Global Biosimilar Manufacturing Cost Analysis

11.1 Biosimilar Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.3 Manufacturing Process Analysis of Biosimilar

12 Global Biosimilar Marketing Channel, Distributors, Customers and Supply Chain

12.1 Marketing Channel

12.2 Biosimilar Distributors List

12.3 Biosimilar Customers

12.4 Biosimilar Supply Chain Analysis

13 Analyst's Viewpoints/Conclusions

14 Disclaimer

Table 1. Research Programs/Design for This Report

Table 2. Key Data Information from Secondary Sources

Table 3. Key Executives Interviewed

Table 4. Key Data Information from Primary Sources

Table 5. Key Players Covered: Ranking by Biosimilar Revenue (US$ Million) 2016-2021

Table 6. Global Biosimilar Market Size by Type (US$ Million): 2022-2027

Table 7. Human Growth Hormones Features

Table 8. Monoclonal Antibodies Features

Table 9. Insulin Features

Table 10. Peptides Features

Table 11. Erythropoietin Features

Table 12. Others Features

Table 16. Global Biosimilar Market Size by Application (US$ Million): 2022-2027

Table 17. Oncology Case Studies

Table 18. Chronic and Autoimmune Diseases Case Studies

Table 19. Growth Hormone Deficiency Case Studies

Table 20. Infectious Diseases Case Studies

Table 21. Others Case Studies

Table 26. Overview of the World Economic Outlook Projections

Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 32. Commodity Prices-Metals Price Indices

Table 33. Commodity Prices- Precious Metal Price Indices

Table 34. Commodity Prices- Agricultural Raw Material Price Indices

Table 35. Commodity Prices- Food and Beverage Price Indices

Table 36. Commodity Prices- Fertilizer Price Indices

Table 37. Commodity Prices- Energy Price Indices

Table 38. G20+: Economic Policy Responses to COVID-19

Table 39. Covid-19 Impact: Global Major Government Policy

Table 40. Biosimilar Report Years Considered

Table 41. Market Top Trends

Table 42. Key Drivers: Impact Analysis

Table 43. Key Challenges

Table 44. Porter's Five Forces Analysis

Table 45. Biosimilar Market Growth Strategy

Table 46. Biosimilar SWOT Analysis

Table 47. Allergan plc Biosimilar Product Specification

Table 48. Allergan plc Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 49. BIOCAD Biosimilar Product Specification

Table 50. BIOCAD Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 51. Biocon Biosimilar Product Specification

Table 52. Biocon Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 53. BioXpress Therapeutics Biosimilar Product Specification

Table 54. Table BioXpress Therapeutics Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 55. Boehringer Ingelheim Biosimilar Product Specification

Table 56. Boehringer Ingelheim Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 57. Celltrion Biosimilar Product Specification

Table 58. Celltrion Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 59. Coherus BioSciences Biosimilar Product Specification

Table 60. Coherus BioSciences Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 61. Dr. Reddy’s Laboratories Biosimilar Product Specification

Table 62. Dr. Reddy’s Laboratories Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 63. Genor BioPharma Biosimilar Product Specification

Table 64. Genor BioPharma Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 65. Intas Pharmaceuticals Limited Biosimilar Product Specification

Table 66. Intas Pharmaceuticals Limited Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 67. Novartis Biosimilar Product Specification

Table 68. Novartis Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 69. Pfizer Biosimilar Product Specification

Table 70. Pfizer Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 71. Reliance Life Sciences Biosimilar Product Specification

Table 72. Reliance Life Sciences Biosimilar Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 147. Global Biosimilar Production Capacity by Market Players

Table 148. Global Biosimilar Production by Market Players (2016-2021)

Table 149. Global Biosimilar Production Market Share by Market Players (2016-2021)

Table 150. Global Biosimilar Revenue by Market Players (2016-2021)

Table 151. Global Biosimilar Revenue Share by Market Players (2016-2021)

Table 152. Global Market Biosimilar Average Price of Key Market Players (2016-2021)

Table 153. North America Key Players Biosimilar Revenue (2016-2021) (US$ Million)

Table 154. North America Key Players Biosimilar Market Share (2016-2021)

Table 155. North America Biosimilar Market Size by Type (2016-2021) (US$ Million)

Table 156. North America Biosimilar Market Share by Type (2016-2021)

Table 157. North America Biosimilar Market Size by Application (2016-2021) (US$ Million)

Table 158. North America Biosimilar Market Share by Application (2016-2021)

Table 159. East Asia Biosimilar Market Size YoY Growth (2016-2021) (US$ Million)

Table 160. East Asia Key Players Biosimilar Revenue (2016-2021) (US$ Million)

Table 161. East Asia Key Players Biosimilar Market Share (2016-2021)

Table 162. East Asia Biosimilar Market Size by Type (2016-2021) (US$ Million)

Table 163. East Asia Biosimilar Market Share by Type (2016-2021)

Table 164. East Asia Biosimilar Market Size by Application (2016-2021) (US$ Million)

Table 165. East Asia Biosimilar Market Share by Application (2016-2021)

Table 166. Europe Biosimilar Market Size YoY Growth (2016-2021) (US$ Million)

Table 167. Europe Key Players Biosimilar Revenue (2016-2021) (US$ Million)

Table 168. Europe Key Players Biosimilar Market Share (2016-2021)

Table 169. Europe Biosimilar Market Size by Type (2016-2021) (US$ Million)

Table 170. Europe Biosimilar Market Share by Type (2016-2021)

Table 171. Europe Biosimilar Market Size by Application (2016-2021) (US$ Million)

Table 172. Europe Biosimilar Market Share by Application (2016-2021)

Table 173. South Asia Biosimilar Market Size YoY Growth (2016-2021) (US$ Million)

Table 174. South Asia Key Players Biosimilar Revenue (2016-2021) (US$ Million)

Table 175. South Asia Key Players Biosimilar Market Share (2016-2021)

Table 176. South Asia Biosimilar Market Size by Type (2016-2021) (US$ Million)

Table 177. South Asia Biosimilar Market Share by Type (2016-2021)

Table 178. South Asia Biosimilar Market Size by Application (2016-2021) (US$ Million)

Table 179. South Asia Biosimilar Market Share by Application (2016-2021)

Table 180. Southeast Asia Biosimilar Market Size YoY Growth (2016-2021) (US$ Million)

Table 181. Southeast Asia Key Players Biosimilar Revenue (2016-2021) (US$ Million)

Table 182. Southeast Asia Key Players Biosimilar Market Share (2016-2021)

Table 183. Southeast Asia Biosimilar Market Size by Type (2016-2021) (US$ Million)

Table 184. Southeast Asia Biosimilar Market Share by Type (2016-2021)

Table 185. Southeast Asia Biosimilar Market Size by Application (2016-2021) (US$ Million)

Table 186. Southeast Asia Biosimilar Market Share by Application (2016-2021)

Table 187. Middle East Biosimilar Market Size YoY Growth (2016-2021) (US$ Million)

Table 188. Middle East Key Players Biosimilar Revenue (2016-2021) (US$ Million)

Table 189. Middle East Key Players Biosimilar Market Share (2016-2021)

Table 190. Middle East Biosimilar Market Size by Type (2016-2021) (US$ Million)

Table 191. Middle East Biosimilar Market Share by Type (2016-2021)

Table 192. Middle East Biosimilar Market Size by Application (2016-2021) (US$ Million)

Table 193. Middle East Biosimilar Market Share by Application (2016-2021)

Table 194. Africa Biosimilar Market Size YoY Growth (2016-2021) (US$ Million)

Table 195. Africa Key Players Biosimilar Revenue (2016-2021) (US$ Million)

Table 196. Africa Key Players Biosimilar Market Share (2016-2021)

Table 197. Africa Biosimilar Market Size by Type (2016-2021) (US$ Million)

Table 198. Africa Biosimilar Market Share by Type (2016-2021)

Table 199. Africa Biosimilar Market Size by Application (2016-2021) (US$ Million)

Table 200. Africa Biosimilar Market Share by Application (2016-2021)

Table 201. Oceania Biosimilar Market Size YoY Growth (2016-2021) (US$ Million)

Table 202. Oceania Key Players Biosimilar Revenue (2016-2021) (US$ Million)

Table 203. Oceania Key Players Biosimilar Market Share (2016-2021)

Table 204. Oceania Biosimilar Market Size by Type (2016-2021) (US$ Million)

Table 205. Oceania Biosimilar Market Share by Type (2016-2021)

Table 206. Oceania Biosimilar Market Size by Application (2016-2021) (US$ Million)

Table 207. Oceania Biosimilar Market Share by Application (2016-2021)

Table 208. South America Biosimilar Market Size YoY Growth (2016-2021) (US$ Million)

Table 209. South America Key Players Biosimilar Revenue (2016-2021) (US$ Million)

Table 210. South America Key Players Biosimilar Market Share (2016-2021)

Table 211. South America Biosimilar Market Size by Type (2016-2021) (US$ Million)

Table 212. South America Biosimilar Market Share by Type (2016-2021)

Table 213. South America Biosimilar Market Size by Application (2016-2021) (US$ Million)

Table 214. South America Biosimilar Market Share by Application (2016-2021)

Table 215. Rest of the World Biosimilar Market Size YoY Growth (2016-2021) (US$ Million)

Table 216. Rest of the World Key Players Biosimilar Revenue (2016-2021) (US$ Million)

Table 217. Rest of the World Key Players Biosimilar Market Share (2016-2021)

Table 218. Rest of the World Biosimilar Market Size by Type (2016-2021) (US$ Million)

Table 219. Rest of the World Biosimilar Market Share by Type (2016-2021)

Table 220. Rest of the World Biosimilar Market Size by Application (2016-2021) (US$ Million)

Table 221. Rest of the World Biosimilar Market Share by Application (2016-2021)

Table 222. North America Biosimilar Consumption by Countries (2016-2021)

Table 223. East Asia Biosimilar Consumption by Countries (2016-2021)

Table 224. Europe Biosimilar Consumption by Region (2016-2021)

Table 225. South Asia Biosimilar Consumption by Countries (2016-2021)

Table 226. Southeast Asia Biosimilar Consumption by Countries (2016-2021)

Table 227. Middle East Biosimilar Consumption by Countries (2016-2021)

Table 228. Africa Biosimilar Consumption by Countries (2016-2021)

Table 229. Oceania Biosimilar Consumption by Countries (2016-2021)

Table 230. South America Biosimilar Consumption by Countries (2016-2021)

Table 231. Rest of the World Biosimilar Consumption by Countries (2016-2021)

Table 232. Global Biosimilar Production Forecast by Region (2022-2027)

Table 233. Global Biosimilar Sales Volume Forecast by Type (2022-2027)

Table 234. Global Biosimilar Sales Volume Market Share Forecast by Type (2022-2027)

Table 235. Global Biosimilar Sales Revenue Forecast by Type (2022-2027)

Table 236. Global Biosimilar Sales Revenue Market Share Forecast by Type (2022-2027)

Table 237. Global Biosimilar Sales Price Forecast by Type (2022-2027)

Table 238. Global Biosimilar Consumption Volume Forecast by Application (2022-2027)

Table 239. Global Biosimilar Consumption Value Forecast by Application (2022-2027)

Table 240. North America Biosimilar Consumption Forecast 2022-2027 by Country

Table 241. East Asia Biosimilar Consumption Forecast 2022-2027 by Country

Table 242. Europe Biosimilar Consumption Forecast 2022-2027 by Country

Table 243. South Asia Biosimilar Consumption Forecast 2022-2027 by Country

Table 244. Southeast Asia Biosimilar Consumption Forecast 2022-2027 by Country

Table 245. Middle East Biosimilar Consumption Forecast 2022-2027 by Country

Table 246. Africa Biosimilar Consumption Forecast 2022-2027 by Country

Table 247. Oceania Biosimilar Consumption Forecast 2022-2027 by Country

Table 248. South America Biosimilar Consumption Forecast 2022-2027 by Country

Table 249. Rest of the world Biosimilar Consumption Forecast 2022-2027 by Country

Table 250. Global Biosimilar Market Size by Type (2016-2021) (US$ Million)

Table 251. Global Biosimilar Revenue Market Share by Type (2016-2021)

Table 252. Global Biosimilar Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 253. Global Biosimilar Revenue Market Share by Type (2022-2027)

Table 254. Global Biosimilar Market Size by Application (2016-2021) (US$ Million)

Table 255. Global Biosimilar Revenue Market Share by Application (2016-2021)

Table 256. Global Biosimilar Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 257. Global Biosimilar Revenue Market Share by Application (2022-2027)

Table 258. Biosimilar Distributors List

Table 259. Biosimilar Customers List





Figure 1. Product Figure

Figure 2. Global Biosimilar Market Share by Type: 2021 VS 2027

Figure 3. Global Biosimilar Market Share by Application: 2021 VS 2027

Figure 4. North America Biosimilar Market Size YoY Growth (2016-2021) (US$ Million)

Figure 5. North America Biosimilar Consumption and Growth Rate (2016-2021)

Figure 6. North America Biosimilar Consumption Market Share by Countries in 2021

Figure 7. United States Biosimilar Consumption and Growth Rate (2016-2021)

Figure 8. Canada Biosimilar Consumption and Growth Rate (2016-2021)

Figure 9. Mexico Biosimilar Consumption and Growth Rate (2016-2021)

Figure 10. East Asia Biosimilar Consumption and Growth Rate (2016-2021)

Figure 11. East Asia Biosimilar Consumption Market Share by Countries in 2021

Figure 12. China Biosimilar Consumption and Growth Rate (2016-2021)

Figure 13. Japan Biosimilar Consumption and Growth Rate (2016-2021)

Figure 14. South Korea Biosimilar Consumption and Growth Rate (2016-2021)

Figure 15. Europe Biosimilar Consumption and Growth Rate

Figure 16. Europe Biosimilar Consumption Market Share by Region in 2021

Figure 17. Germany Biosimilar Consumption and Growth Rate (2016-2021)

Figure 18. United Kingdom Biosimilar Consumption and Growth Rate (2016-2021)

Figure 19. France Biosimilar Consumption and Growth Rate (2016-2021)

Figure 20. Italy Biosimilar Consumption and Growth Rate (2016-2021)

Figure 21. Russia Biosimilar Consumption and Growth Rate (2016-2021)

Figure 22. Spain Biosimilar Consumption and Growth Rate (2016-2021)

Figure 23. Netherlands Biosimilar Consumption and Growth Rate (2016-2021)

Figure 24. Switzerland Biosimilar Consumption and Growth Rate (2016-2021)

Figure 25. Poland Biosimilar Consumption and Growth Rate (2016-2021)

Figure 26. South Asia Biosimilar Consumption and Growth Rate

Figure 27. South Asia Biosimilar Consumption Market Share by Countries in 2021

Figure 28. India Biosimilar Consumption and Growth Rate (2016-2021)

Figure 29. Southeast Asia Biosimilar Consumption and Growth Rate

Figure 30. Southeast Asia Biosimilar Consumption Market Share by Countries in 2021

Figure 31. Indonesia Biosimilar Consumption and Growth Rate (2016-2021)

Figure 32. Thailand Biosimilar Consumption and Growth Rate (2016-2021)

Figure 33. Singapore Biosimilar Consumption and Growth Rate (2016-2021)

Figure 34. Malaysia Biosimilar Consumption and Growth Rate (2016-2021)

Figure 35. Philippines Biosimilar Consumption and Growth Rate (2016-2021)

Figure 36. Middle East Biosimilar Consumption and Growth Rate

Figure 37. Middle East Biosimilar Consumption Market Share by Countries in 2021

Figure 38. Turkey Biosimilar Consumption and Growth Rate (2016-2021)

Figure 39. Saudi Arabia Biosimilar Consumption and Growth Rate (2016-2021)

Figure 40. Iran Biosimilar Consumption and Growth Rate (2016-2021)

Figure 41. United Arab Emirates Biosimilar Consumption and Growth Rate (2016-2021)

Figure 42. Africa Biosimilar Consumption and Growth Rate

Figure 43. Africa Biosimilar Consumption Market Share by Countries in 2021

Figure 44. Nigeria Biosimilar Consumption and Growth Rate (2016-2021)

Figure 45. South Africa Biosimilar Consumption and Growth Rate (2016-2021)

Figure 46. Oceania Biosimilar Consumption and Growth Rate

Figure 47. Oceania Biosimilar Consumption Market Share by Countries in 2021

Figure 48. Australia Biosimilar Consumption and Growth Rate (2016-2021)

Figure 49. South America Biosimilar Consumption and Growth Rate

Figure 50. South America Biosimilar Consumption Market Share by Countries in 2021

Figure 51. Brazil Biosimilar Consumption and Growth Rate (2016-2021)

Figure 52. Argentina Biosimilar Consumption and Growth Rate (2016-2021)

Figure 53. Rest of the World Biosimilar Consumption and Growth Rate

Figure 54. Rest of the World Biosimilar Consumption Market Share by Countries in 2021

Figure 55. Global Biosimilar Production Capacity Growth Rate Forecast (2022-2027)

Figure 56. Global Biosimilar Revenue Growth Rate Forecast (2022-2027)

Figure 57. Global Biosimilar Price and Trend Forecast (2022-2027)

Figure 58. North America Biosimilar Production Growth Rate Forecast (2022-2027)

Figure 59. North America Biosimilar Revenue Growth Rate Forecast (2022-2027)

Figure 60. East Asia Biosimilar Production Growth Rate Forecast (2022-2027)

Figure 61. East Asia Biosimilar Revenue Growth Rate Forecast (2022-2027)

Figure 62. Europe Biosimilar Production Growth Rate Forecast (2022-2027)

Figure 63. Europe Biosimilar Revenue Growth Rate Forecast (2022-2027)

Figure 64. South Asia Biosimilar Production Growth Rate Forecast (2022-2027)

Figure 65. South Asia Biosimilar Revenue Growth Rate Forecast (2022-2027)

Figure 66. Southeast Asia Biosimilar Production Growth Rate Forecast (2022-2027)

Figure 67. Southeast Asia Biosimilar Revenue Growth Rate Forecast (2022-2027)

Figure 68. Middle East Biosimilar Production Growth Rate Forecast (2022-2027)

Figure 69. Middle East Biosimilar Revenue Growth Rate Forecast (2022-2027)

Figure 70. Africa Biosimilar Production Growth Rate Forecast (2022-2027)

Figure 71. Africa Biosimilar Revenue Growth Rate Forecast (2022-2027)

Figure 72. Oceania Biosimilar Production Growth Rate Forecast (2022-2027)

Figure 73. Oceania Biosimilar Revenue Growth Rate Forecast (2022-2027)

Figure 74. South America Biosimilar Production Growth Rate Forecast (2022-2027)

Figure 75. South America Biosimilar Revenue Growth Rate Forecast (2022-2027)

Figure 76. Rest of the World Biosimilar Production Growth Rate Forecast (2022-2027)

Figure 77. Rest of the World Biosimilar Revenue Growth Rate Forecast (2022-2027)

Figure 78. North America Biosimilar Consumption Forecast 2022-2027

Figure 79. East Asia Biosimilar Consumption Forecast 2022-2027

Figure 80. Europe Biosimilar Consumption Forecast 2022-2027

Figure 81. South Asia Biosimilar Consumption Forecast 2022-2027

Figure 82. Southeast Asia Biosimilar Consumption Forecast 2022-2027

Figure 83. Middle East Biosimilar Consumption Forecast 2022-2027

Figure 84. Africa Biosimilar Consumption Forecast 2022-2027

Figure 85. Oceania Biosimilar Consumption Forecast 2022-2027

Figure 86. South America Biosimilar Consumption Forecast 2022-2027

Figure 87. Rest of the world Biosimilar Consumption Forecast 2022-2027

Figure 88. Manufacturing Cost Structure of Biosimilar

Figure 89. Manufacturing Process Analysis of Biosimilar

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Biosimilar Supply Chain Analysis
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Biosimilar Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027 Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Biosimilar Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027 Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Biosimilar Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027 Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports